Sort
53,477 grants matching “addiction”
Advancing Diversity in Addiction Research Training
$377,587Sudie E Back · Medical University Of South Carolina · R25 · FY2022 · DA
Advancing Diversity in Addiction Research Training
$377,587Sudie E Back · Medical University Of South Carolina · R25 · FY2023 · DA
Dynamic Mechanisms of GPCRs Targeted by Drugs of Abuse
$377,561Marta Filizola · Icahn School Of Medicine At Mount Sinai · R01 · FY2016 · DA
Mechanisms underlying memory stabilization
$377,561Cristina M Alberini · Icahn School Of Medicine At Mount Sinai · R01 · FY2011 · MH
Treatment Study Using Depot Naltrexone(3/6)NY/Bellevue Protocol Treatment Site
$377,561Joshua D Lee · New York University School Of Medicine · R01 · FY2010 · DA
Post-translational regulation of opioid receptors
$377,561Lakshmi A Devi · Icahn School Of Medicine At Mount Sinai · R01 · FY2010 · DA
Human Genetics of Nicotine Addiction
$377,487Mark F Leppert · University Of Utah · P01 · FY2006 · HL
Administrative Core
$377,454James A Hoxie · University Of Pennsylvania · P30 · FY2017 · AI
Targeting KSHV malignancies and persistent infection
$377,438Shou-Jiang Gao · University Of Southern California · R01 · FY2017 · CA
Targeting KSHV malignancies and persistent infection
$377,438Shou-Jiang Gao · University Of Southern California · R01 · FY2016 · CA
Non-peptide Mu Opioid Receptor Selective Antagonists
$377,437Yan Zhang · Virginia Commonwealth University · R01 · FY2016 · DA
Role of Gut Microbiome- Brain Axis in Modulating CNS Inflammasomes in the Neuropathology Produced by Opioid Exposure and HIV
$377,433Sabita Roy · University Of Miami School Of Medicine · R01 · FY2019 · DA
The nociceptin ORL1 System: Treatment Target for Relapse
$377,424Friedbert Weiss · Scripps Research Institute, The · R01 · FY2011 · AA
The nociceptin ORL1 System: Treatment Target for Relapse
$377,424Friedbert Weiss · Scripps Research Institute, The · R01 · FY2012 · AA
Functional Imaging of Mu and Delta Opioid Receptors In Vivo: Receptor Dynamics
$377,421Brigitte L Kieffer · University Of California Los Angeles · P50 · FY2009 · DA
Dopamine Regulation During Context Processing
$377,403Sheri J. Y. Mizumori · University Of Washington · R01 · FY2012 · MH
Mentoring the next generation of addiction clinician scientists while responding to the opioid epidemic
$377,402Nadia Fairbairn · University Of British Columbia · R25 · FY2019 · DA
Basal Ganglia Pathways for Stopping and Switching
$377,400Joshua D Berke · University Of Michigan At Ann Arbor · R01 · FY2013 · MH
Combined Voltammetry/Electrophysiology in Behaving Rats
$377,374Regina M Carelli · Univ Of North Carolina Chapel Hill · R01 · FY2008 · DA
The role of the nociceptor endocytosis in inflammatory pain
$377,364Arindam Bhattacharjee · State University Of New York At Buffalo · R01 · FY2022 · NS
Cognitive-enhancing DA Medications for Cocaine Dependence
$377,360Joy Marie Schmitz · University Of Texas Hlth Sci Ctr Houston · R01 · FY2011 · DA
HEAL - ASSESSMENT OF POTENTIAL SUBSTANCE ABUSE TREATMENT MEDICATIONS IN NONHUMAN PRIMATE MODELS. NIDA REF. NO. N01DA-19-8946; POP: 12/16/2018-12/15/2022.
$377,356Jack Bergman · Mclean Hospital · N01 · FY2023 · DA
Mechanisms of Neuronal Specific Transcription
$377,348Harvard University (Medical School) · R01 · FY2004 · HD
Classification of Substance Use Severity and Treatment Outcomes: NIDA CTN Studies
$377,303Li-Tzy T Wu · Duke University · R33 · FY2010 · DA
Physiology and Pharmacology of Brain Reward Circuits
$377,271Carl R. Lupica · National Institute On Drug Abuse · ZIA · FY2009 · DA